CIK 0001628171
- Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472029180
- Phone
- +1 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- 4 Planned sale GOLDSMITH MARK A sold 8,165 shares at $25.90 ($211,488)
- 4 Planned sale General Counsel sold 1,229 shares at $25.90 ($31,833)
- 4 Planned sale Kelsey Stephen Michael sold 2,088 shares at $25.90 ($54,083)
- 4 Planned sale Chief Operating Officer sold 7,993 shares at an average $26.36 ($210,707)
- 4 Planned sale Chief Operating Officer sold 5,000 shares at $25.00 ($125,000)
- 4 Planned sale General Counsel sold 1,500 shares at $21.70 ($32,545)
- 4 Grant or award Director acquired 90,487 shares (grant or award)
- 4 Grant or award Director acquired 2,091,672 shares (grant or award)
- 4 Grant or award Director acquired 1,457,211 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Chief Operating Officer acquired 7,500 shares (option exercise)
- 4 Exercise or conversion Director acquired 35,000 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 24,524 shares (option exercise)
- 4 Planned sale Chief Operating Officer sold 25,000 shares at an average $33.95 ($848,806)
- 4 Planned sale Kelsey Stephen Michael sold 16,667 shares at $29.05 ($484,130)
- 4 Planned sale General Counsel sold 2,000 shares at an average $28.20 ($56,394)
- 4 Open-market sale Kelsey Stephen Michael sold 2,060 shares at $31.31 ($64,500)
- 4 Open-market sale Director sold 8,054 shares at $31.31 ($252,175)
- 4 Open-market sale General Counsel sold 1,214 shares at $31.31 ($38,011)
- 4 Open-market sale Chief Financial Officer sold 1,427 shares at $31.31 ($44,680)
Page 11 of 21 · 414 filings